Dabigatran
Atrial Septal Aneurysm
Assistance Publique - Hôpitaux de ParisPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Atrial Septal Aneurysm cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Apixaban Assistance Publique - Hôpitaux de Paris | Phase 3 | BB |
Acetylsalicylic Acid Assistance Publique - Hôpitaux de Paris | Phase 3 | BB |
Rivaroxaban Assistance Publique - Hôpitaux de Paris | Phase 3 | BB |
Same molecule, other indications
Dabigatran is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →